Who Owns Ironwood Pharmaceuticals Stock?
NASDAQ: IRWDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 97.48%
- Institutions (% of float)
- 101.03%
- Held by insiders
- 3.51%
- Institutional holders
- 310
- Institutions 96.5%
- Insiders 3.5%
- Public and other 0.0%
Who owns Ironwood Pharmaceuticals stock?
Institutional investors own about 97.5% of Ironwood Pharmaceuticals's shares, spread across 310 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.51% of IRWD.
The largest institutional holders are Blackrock Inc. (11.16%), Armistice Capital, LLC (8.42%) and Sarissa Capital Management, LP (5.55%). Together, the top 10 institutions control 53.3% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their IRWD positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IRWD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 18.48M | 11.16% | +3.9% |
| Armistice Capital, LLC | 13.93M | 8.42% | -7.3% |
| Sarissa Capital Management, LP | 9.19M | 5.55% | 0.0% |
| Bank of America Corporation | 8.68M | 5.25% | +0.0% |
| Renaissance Technologies, LLC | 8.04M | 4.86% | +0.6% |
| State Street Corporation | 6.72M | 4.06% | -23.7% |
| Vanguard Capital Management LLC | 6.63M | 4.01% | +0.4% |
| AQR Capital Management, LLC | 6.47M | 3.91% | -14.2% |
| Vanguard Portfolio Management LLC | 5.06M | 3.06% | -8.2% |
| Acadian Asset Management. LLC | 5.05M | 3.05% | -13.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IRWD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.78M | 2.89% |
| iShares Trust-iShares Russell 2000 ETF | 4.25M | 2.57% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.32M | 2.01% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 1.83M | 1.11% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.79M | 1.08% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.68M | 1.01% |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 1.62M | 0.98% |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.46M | 0.88% |
| Vanguard Explorer Fund | 1.40M | 0.85% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 1.29M | 0.78% |
Frequently asked questions
Who is the largest shareholder of Ironwood Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of IRWD, owning 11.16% of shares outstanding (18.48M shares) as of its latest 13F filing.
What percentage of Ironwood Pharmaceuticals is owned by institutions?
Institutions own about 97.5% of IRWD shares and 101.0% of the public float.
How much of Ironwood Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 3.51% of IRWD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.